What is Amneal Pharmaceuticals, Inc.'s R&D?

Amneal Pharmaceuticals, Inc. (AMRX) reported R&D of $38.38M in Q1 2026.

How has Amneal Pharmaceuticals, Inc.'s R&D changed year-over-year?

Amneal Pharmaceuticals, Inc.'s R&D decreased by 4.1% year-over-year, from $40.04M to $38.38M.

What is the long-term trend for Amneal Pharmaceuticals, Inc.'s R&D?

Over 4 years (2021 to 2025), Amneal Pharmaceuticals, Inc.'s R&D has grown at a -2.0% compound annual growth rate (CAGR), from $201.85M to $186.18M.

Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.

Amneal Pharmaceuticals, Inc. AMRX R&D

R&D at other companies

Jazz PharmaceuticalsJAZZ

$196M+8.5%

ViatrisVTRS

$248.6M+12.0%

Catalyst PharmaceuticalCPRX

$2.66M-31.5%

Neurocrine BiosciencesNBIX

$296.2M+12.5%

BridgeBio PharmaBBIO

$126.64M+13.6%

AmgenAMGN

$1.72B+15.7%

Segments

By segment

See full

Affordable Medicines$28.01M-42.4%

Specialty$9.06M+83.9%

AvKARE$0—

Other financials

Income statement

See full

Revenue$722.5M+3.9%

Gross profit$320.1M+25.1%

Operating income$141.8M+41.3%

Net income$62.3M+411%

EPS (diluted)$0.19+375%

Balance sheet

See full

Cash & equivalents$197.7M+234%

Total debt$2.6B+17.7%

Total equity-$45.4M+65.5%

Total assets$3.5B+5.2%

Cash flow

See full

Operating cash flow-$26.7M-461%

CapEx$8.2M-37.9%

Free cash flow-$34.9M-507%

Valuation

See full

Market cap$5.17B+51.0%

Profitability

See full

Gross margin38.7%+2.0pp

Operating margin14.3%+1.6pp

Net margin4%+3.6pp

FCF margin7.9%-1.0pp

Returns & leverage

See full

Return on equity-52.8%-12.7pp

Debt / equity127.9×+119×

Current ratio2.5×+1.1×

Where this comes from

Reported directly by Amneal Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: Amneal Pharmaceuticals, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Amneal Pharmaceuticals, Inc.'s r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Amneal Pharmaceuticals, Inc.'s R&D?: Amneal Pharmaceuticals, Inc. (AMRX) reported R&D of $38.38M in Q1 2026.
How has Amneal Pharmaceuticals, Inc.'s R&D changed year-over-year?: Amneal Pharmaceuticals, Inc.'s R&D decreased by 4.1% year-over-year, from $40.04M to $38.38M.
What is the long-term trend for Amneal Pharmaceuticals, Inc.'s R&D?: Over 4 years (2021 to 2025), Amneal Pharmaceuticals, Inc.'s R&D has grown at a -2.0% compound annual growth rate (CAGR), from $201.85M to $186.18M.
What does R&D mean?: Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.